Castle Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 3.19 M | $72.63 M | 1.12% | 11.03% |
| VANGUARD GROUP INC | 11/07/2025 | 2.17 M | $49.46 M | 0.11% | 7.51% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 1.79 M | $40.86 M | -0.26% | 6.21% |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 11/13/2025 | 1.52 M | $34.50 M | 1.71% | 5.24% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.47 M | $33.56 M | 6.97% | 5.10% |
| NUVEEN, LLC | 11/12/2025 | 957.08 K | $21.79 M | -10.81% | 3.31% |
| BRAIDWELL LP | 11/14/2025 | 822.74 K | $18.73 M | 0.00% | 2.85% |
| STATE STREET CORP | 11/14/2025 | 724.08 K | $16.49 M | 2.32% | 2.50% |
| AIGH CAPITAL MANAGEMENT LLC | 10/31/2025 | 707.29 K | $16.10 M | 100.00% | 2.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 698.61 K | $15.91 M | 1.26% | 2.42% |
| WASATCH ADVISORS LP | 11/14/2025 | 669.12 K | $15.24 M | -36.26% | 2.31% |
| ALLIANZ ASSET MANAGEMENT GMBH | 11/04/2025 | 648.35 K | $14.76 M | -9.16% | 2.24% |
| PALISADE CAPITAL MANAGEMENT, LP | 11/14/2025 | 638.66 K | $14.54 M | 11.05% | 2.21% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 575.09 K | $13.09 M | 34.24% | 1.99% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 562.60 K | $12.81 M | -16.09% | 1.95% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 494.95 K | $11.07 M | -23.69% | 1.71% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 475.57 K | $10.83 M | 35.00% | 1.64% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 451.65 K | $10.28 M | -17.01% | 1.56% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 11/14/2025 | 400.00 K | $9.11 M | 100.00% | 1.38% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 11/14/2025 | 367.89 K | $8.38 M | 31.41% | 1.27% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 345.10 K | $7.86 M | 26.21% | 1.19% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 336.96 K | $7.67 M | 100.00% | 1.17% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/13/2025 | 335.89 K | $7.65 M | 165.67% | 1.16% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 315.37 K | $7.18 M | -17.60% | 1.09% |
| UBS GROUP AG | 11/13/2025 | 291.36 K | $6.63 M | -19.92% | 1.01% |
| NORTHERN TRUST CORP | 11/14/2025 | 282.27 K | $6.43 M | 0.87% | 0.98% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 10/31/2025 | 278.31 K | $6.34 M | 0.00% | 0.96% |
| MORGAN STANLEY | 11/14/2025 | 269.63 K | $6.14 M | 60.89% | 0.93% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 256.23 K | $5.83 M | -31.21% | 0.89% |
| ADVISORS CAPITAL MANAGEMENT, LLC | 11/07/2025 | 254.20 K | $5.79 M | 3.39% | 0.88% |
| CITADEL ADVISORS LLC | 11/14/2025 | 250.92 K | $5.71 M | -71.76% | 0.87% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 238.15 K | $5.42 M | 1.34% | 0.82% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/03/2025 | 230.05 K | $5.24 M | 6.59% | 0.80% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 220.96 K | $5.03 M | 14.75% | 0.76% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 178.44 K | $4.06 M | -43.90% | 0.62% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 177.18 K | $4.03 M | 334.80% | 0.61% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 10/20/2025 | 156.51 K | $3.56 M | -2.89% | 0.54% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 139.91 K | $3.19 M | 40.91% | 0.48% |
| BIRCHVIEW CAPITAL, LP | 11/13/2025 | 110.60 K | $2.52 M | 0.00% | 0.38% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 99.79 K | $2.27 M | 0.54% | 0.35% |
| EMPOWERED FUNDS, LLC | 11/13/2025 | 98.18 K | $2.24 M | 140.93% | 0.34% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 94.02 K | $2.14 M | 4.60% | 0.33% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 92.61 K | $2.11 M | -37.50% | 0.32% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 87.69 K | $2.00 M | 29.10% | 0.30% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2025 | 85.44 K | $1.95 M | 11.75% | 0.30% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 82.51 K | $1.88 M | 26.41% | 0.29% |
| BRINKER CAPITAL INVESTMENTS, LLC | 11/12/2025 | 76.34 K | $1.74 M | -0.25% | 0.26% |
| BARCLAYS PLC | 11/12/2025 | 73.07 K | $1.66 M | -33.42% | 0.25% |
| ENVESTNET ASSET MANAGEMENT INC | 11/05/2025 | 66.93 K | $1.52 M | -5.04% | 0.23% |
| ALGERT GLOBAL LLC | 11/14/2025 | 57.90 K | $1.32 M | -68.74% | 0.20% |
Castle Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 221 institutional investors and hedge funds held shares of Castle Biosciences, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 3.19 M
VANGUARD GROUP INC: 2.17 M
PRINCIPAL FINANCIAL GROUP INC: 1.79 M
Portolan Capital Management, LLC: 1.52 M
DIMENSIONAL FUND ADVISORS LP: 1.47 M
Nuveen, LLC: 957,081
91.74% of Castle Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 30.97 M shares in the last 24 months. This purchase volume represents approximately $1.23 B in transactions.